INTERNATIONAL BIOTECHNOLOGY TRUST PLC - ASCENDIS PHARMA A/S ownership

Back to all holdings Add to watchlist

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 130 filers reported holding ASCENDIS PHARMA A/S in Q3 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.9%.

Links
Filings
External links
Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q1 2023$3,151,092
-12.2%
29,4000.0%0.88%
-20.7%
Q4 2022$3,588,270
+18.2%
29,4000.0%1.11%
+13.8%
Q3 2022$3,036,000
-89.7%
29,400
+975.7%
0.97%
+217.3%
Q2 2022$29,400,000
+1406.9%
2,733
-90.7%
0.31%
-30.2%
Q1 2022$1,951,000
-50.7%
29,4000.0%0.44%
-50.1%
Q4 2021$3,955,000
-15.6%
29,4000.0%0.88%
-22.0%
Q3 2021$4,686,000
+158.2%
29,400
+113.0%
1.13%
+135.9%
Q2 2021$1,815,000
+2.3%
13,8000.0%0.48%
+2.1%
Q1 2021$1,775,000
-22.8%
13,8000.0%0.47%
-25.3%
Q4 2020$2,298,000
+8.1%
13,8000.0%0.63%
-8.5%
Q3 2020$2,125,000
+6.3%
13,8000.0%0.69%
+3.3%
Q2 2020$1,999,000
+29.1%
13,8000.0%0.66%
-5.9%
Q1 2020$1,548,000
-19.3%
13,8000.0%0.71%
+2.2%
Q4 2019$1,918,000
+44.3%
13,8000.0%0.69%
+12.5%
Q3 2019$1,329,000
-55.2%
13,800
-46.5%
0.61%
-44.2%
Q2 2019$2,969,000
+82.8%
25,800
+87.0%
1.10%
+83.5%
Q1 2019$1,624,000–13,800–0.60%–
 Download
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2019
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,797,745$265,886,00019.06%
RA Capital Management 4,914,955$726,922,00014.16%
Sofinnova Investments, Inc. 1,109,874$164,150,00010.35%
Eventide Asset Management 1,709,848$252,887,0005.50%
Asymmetry Capital Management, L.P. 47,599$7,040,0005.39%
BERYLSON CAPITAL PARTNERS, LLC 58,200$8,608,0005.30%
Avoro Capital Advisors LLC 1,750,000$258,825,0005.12%
Eversept Partners, LP 220,344$32,588,8784.47%
Spyglass Capital Management LLC 452,104$66,866,0004.14%
Orbimed Advisors 1,562,986$231,166,0003.25%
View complete list of ASCENDIS PHARMA A/S shareholders